Potencjalne możliwości wykorzystania berberyny w przeciwdziałaniu insulinooporności i w cukrzycy typu 2
DOI: https://doi.org/10.2478/ahem-2021-0038 | Journal eISSN: 1732-2693
Language: English
Page range: 790 - 801
Submitted on: Oct 30, 2020
Accepted on: Jul 14, 2021
Published on: Nov 29, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2021 Michalina Mróz, Katarzyna Pastusiak, Paweł Bogdański, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.